Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cybin ( (HELP) ) has shared an announcement.
Helus Pharma has appointed veteran life sciences executive Jill Conwell as Chief People Officer, adding deep experience in organizational strategy, talent development, and corporate communications as the company prepares for its next phase of growth. Conwell’s background at Aclaris Therapeutics, Idera Pharmaceuticals, and Shire Pharmaceuticals is expected to help Helus strengthen its culture, attract specialized talent, and scale its operations as it advances its clinical programs in mental health.
The leadership move comes as Helus pushes forward its pipeline of novel serotonergic agonists targeting major depressive disorder and generalized anxiety disorder, underscoring the company’s efforts to mature its organizational infrastructure in parallel with late-stage drug development. By bolstering its executive bench with a strategic people leader, Helus aims to better position itself in the competitive neuropsychiatric therapeutics market and support stakeholders through a period of anticipated clinical and corporate inflection.
The most recent analyst rating on (HELP) stock is a Buy with a $95.00 price target. To see the full list of analyst forecasts on Cybin stock, see the HELP Stock Forecast page.
More about Cybin
Helus Pharma, the commercial operating name of Cybin Inc., is a clinical-stage pharmaceutical company focused on developing proprietary novel serotonergic agonists, or NSAs, synthetic molecules designed to activate serotonin pathways believed to promote neuroplasticity. Its lead candidates include HLP003, in Phase 3 for adjunctive treatment of major depressive disorder with Breakthrough Therapy Designation from the U.S. Food and Drug Administration, and HLP004, in Phase 2 for generalized anxiety disorder, with operations spanning Canada, the United States, the United Kingdom, and Ireland.
Average Trading Volume: 841,952
Technical Sentiment Signal: Sell
Current Market Cap: $1.41M
For an in-depth examination of HELP stock, go to TipRanks’ Overview page.